000 | 01102cam a22003137a 4500 | ||
---|---|---|---|
001 | 13901793 | ||
005 | 20240731155041.0 | ||
008 | 050316s2004 sz a b i001 0 eng | ||
010 | _a 2005361971 | ||
016 | 7 |
_a101236280 _2DNLM |
|
020 | _a9789241562355 (pbk.) | ||
035 | _a(OCoLC)ocm55058464 | ||
040 |
_aNLM _cNLM _dCOU _dOUN _dORE _dVAM _dBNCHL _dMUQ _dDLC |
||
082 | 0 | 0 | _a615.788 WOR |
100 | _aWorld Health Organization. | ||
245 | 0 | 0 |
_aNeuroscience of psychoactive substance use and dependence / _cWorld Health Organization. |
260 |
_aGeneva : _bWorld Health Organization, _c2004. |
||
300 |
_axx, 264 pages, _bill. (some col.) ; _c24 cm. |
||
500 | _aGratis Bapu trust | ||
650 | 0 |
_aPsychotropic drugs _xPhysiological effect. |
|
650 | 0 |
_aSubstance abuse _xPhysiological aspects. |
|
650 | 1 | 2 | _aSubstance-Related Disorders. |
650 | 2 | 2 |
_aBrain _xphysiopathology. |
650 | 2 | 2 |
_aPsychotropic Drugs _xpharmacology. |
650 | 6 |
_aPsychotropes _xEffets physiologiques. |
|
650 | 6 |
_aPolytoxicomanie _xAspect physiologique. |
|
650 | 6 | _aPsychopharmacologie. | |
942 |
_2ddc _cBK |
||
999 |
_c120005 _d120005 |